Concepedia

David Sanborn

DS

Statistics

Publications

3

Citations

111

H-Index

3

Active since

1994

Affiliations

Heidelberg University(Current)

David Sanborn is an author at Heidelberg University specializing in medicine, immunology, and ovarian cancer.

Top concepts

Publications per year

1994–1997

3

Publications

3

Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.

Leslie R. Coney, Delia Mezzanzanica, David Sanborn et al. · PubMed · 1994 · 61 citations

, , +19

Apoptotic cell death induced by a mouse‐human anti‐APO‐1 chimeric antibody leads to tumor regression

Leslie R. Coney, Peter T. Daniel, David Sanborn et al. · International Journal of Cancer · 1994 · 26 citations

Chimeric Bispecific OC/TR Monoclonal Antibody Mediates Lysis of Tumor Cells Expressing the Folate-Binding Protein (MOv18) and Displays Decreased Immunogenicity in Patients

Rosalie M. Luiten, Sven O. Warnaar, David Sanborn et al. · Journal of Immunotherapy · 1997 · 24 citations

, , +18

1–3 of 3